Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CFO David Afshar Buys 10,000 Shares
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CFO David Afshar Buys 10,000 Shares
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Rating) CFO David Afshar purchased 10,000 shares of the firm's stock in a transaction dated Wednesday, August 24th. The shares were bought at an average price of $2.01 per share, with a total value of $20,100.00. Following the purchase, the chief financial officer now owns 288,240 shares in the company, valued at $579,362.40. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Aveanna Healthcare Holdings Inc.首席財務官大衞·阿夫沙爾在一筆日期為8月24日(星期三)的交易中購買了10,000股該公司股票。這些股票是以每股2.01美元的平均價格購買的,總價值為20,100.00美元。收購完成後,這位首席財務官現在擁有該公司288,240股票,價值579,362.40美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,可以通過這個超級鏈接獲得。
Aveanna Healthcare Price Performance
Aveanna醫療保健價格表現
NASDAQ:AVAH traded up $0.01 during trading hours on Wednesday, hitting $1.93. The stock had a trading volume of 171,881 shares, compared to its average volume of 447,102. The company has a 50 day simple moving average of $2.28 and a two-hundred day simple moving average of $3.31. The company has a debt-to-equity ratio of 6.19, a current ratio of 0.81 and a quick ratio of 0.81. Aveanna Healthcare Holdings Inc. has a one year low of $1.89 and a one year high of $9.91. The firm has a market capitalization of $358.82 million, a price-to-earnings ratio of -0.62 and a beta of 1.03.
納斯達克:Avah週三在交易時段上漲0.01美元,至1.93美元。該股成交量為171,881股,而其平均成交量為447,102股。該公司的50日簡單移動均線切入位在2.28美元,200日簡單移動均線切入位在3.31美元。該公司的債務權益比為6.19,流動比率為0.81,速動比率為0.81。Aveanna Healthcare Holdings Inc.的股價一年來最低為1.89美元,一年來最高為9.91美元。該公司的市值為3.582億美元,市盈率為-0.62倍,貝塔係數為1.03。
Aveanna Healthcare (NASDAQ:AVAH – Get Rating) last announced its quarterly earnings results on Wednesday, August 10th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.03). Aveanna Healthcare had a negative net margin of 33.32% and a positive return on equity of 9.57%. During the same quarter in the prior year, the company earned $0.08 earnings per share. Research analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.16 earnings per share for the current fiscal year.
Aveanna Healthcare(納斯達克:AVAH-GET評級)最近一次公佈季度收益是在8月10日星期三。該公司公佈本季度每股收益為0.03美元,低於普遍預期的0.06美元(0.03美元)。Aveanna Healthcare的淨利潤率為負33.32%,股本回報率為正9.57%。去年同期,該公司每股收益為0.08美元。研究分析師預測,Aveanna Healthcare Holdings Inc.本財年每股收益將為0.16美元。
Institutional Inflows and Outflows
機構資金流入和流出
Analysts Set New Price Targets
分析師設定新的價格目標
Several equities research analysts have recently issued reports on the stock. Stephens decreased their price target on shares of Aveanna Healthcare to $2.75 in a research note on Friday, July 22nd. Credit Suisse Group decreased their price target on shares of Aveanna Healthcare to $5.50 in a research note on Friday, July 22nd. Raymond James cut their price objective on shares of Aveanna Healthcare from $8.00 to $6.00 and set a "strong-buy" rating for the company in a report on Monday, August 15th. Bank of America downgraded shares of Aveanna Healthcare from a "neutral" rating to an "underperform" rating and cut their price objective for the stock from $3.00 to $2.00 in a report on Tuesday, June 21st. Finally, Jefferies Financial Group downgraded shares of Aveanna Healthcare from a "buy" rating to a "hold" rating and set a $2.50 price objective for the company. in a report on Friday, July 22nd. One analyst has rated the stock with a sell rating, three have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $5.33.
幾位股票研究分析師最近發佈了關於該股的報告。斯蒂芬斯在7月22日星期五的一份研究報告中將Aveanna Healthcare的股票目標價下調至2.75美元。瑞士信貸集團在7月22日星期五的一份研究報告中將Aveanna Healthcare的股票目標價下調至5.50美元。雷蒙德·詹姆斯在8月15日週一的一份報告中將Aveanna Healthcare的股票目標價從8.00美元下調至6.00美元,併為該公司設定了“強力買入”評級。在6月21日星期二的一份報告中,美國銀行將Aveanna Healthcare的股票評級從中性下調至表現不佳,並將該股的目標價從3.00美元下調至2.00美元。最後,傑富瑞金融集團將Aveanna Healthcare的股票評級從買入下調至持有,併為該公司設定了2.50美元的目標價。在7月22日星期五的一份報告中。一名分析師對該股的評級為賣出,三名分析師給出了持有評級,五名分析師給出了買入評級,一名分析師對該公司發出了強烈的買入評級。根據MarketBeat的數據,該股的平均評級為“適度買入”,共識目標價為5.33美元。
About Aveanna Healthcare
關於Aveanna Healthcare
(Get Rating)
(獲取評級)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.
Aveanna Healthcare Holdings Inc是一家多元化的家庭護理平臺公司,在美國提供私人值班護理(PDN)、成人家庭健康和臨終關懷、家庭兒科治療和腸內營養服務。其以患者為中心的護理交付平臺允許患者留在家裏,並最大限度地減少對醫院等高成本護理機構的過度利用。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on Aveanna Healthcare (AVAH)
- NYSE Stocks Give Investors a Variety of Quality Options
- Zoom Video Communications Valuation Is Realigned With Reality
- The J.M. Smucker Company Proves Why Staples Are Outperforming
- Will the Real Palantir Please Stand Up?
- Foot Locker Just Because A Very Tempting Buy
- 免費獲取StockNews.com關於Aveanna Healthcare(Avah)的研究報告
- 紐約證交所股票為投資者提供多種優質選擇
- ZOOM視頻通信估值與現實重新接軌
- J.M.斯莫克公司證明瞭史泰博表現優異的原因
- 請真正的Palantir站起來好嗎?
- 只因為買了一件非常誘人的東西就買了腳鎖
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
接受Aveanna Healthcare Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Aveanna Healthcare和相關公司的最新新聞和分析師評級的每日簡要摘要。